BRIEF published on 01/14/2025 at 15:55, 1 year 7 months ago Le groupe Vanguard révèle sa participation dans Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Négoce De Titres Divulgation Des Enjeux Ligne Directe
PRESS RELEASE published on 01/14/2025 at 15:50, 1 year 7 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.49% ownership in Direct Line Insurance Group plc. Form 8.3 details purchases and sales of relevant securities Form 8.3 The Vanguard Group Ownership Disclosure Securities Transactions Direct Line Insurance Group Plc
BRIEF published on 01/13/2025 at 15:31, 1 year 7 months ago Vanguard Group's Disclosure on Direct Line Insurance Group Form 8.3 Takeover Code Vanguard Group Shareholding Disclosure Direct Line Insurance
BRIEF published on 01/13/2025 at 15:31, 1 year 7 months ago Divulgation du groupe Vanguard sur Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Divulgation Des Actions Assurance Ligne Directe
PRESS RELEASE published on 01/13/2025 at 15:26, 1 year 7 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.49% interest in Direct Line Insurance Group plc. Additional disclosure on Aviva plc. Dealings include sale of 27,760 securities at 2.56 GBP per unit Disclosure The Vanguard Group Securities Sale Direct Line Insurance Group Aviva Plc
BRIEF published on 01/09/2025 at 15:12, 1 year 8 months ago Vanguard Group Discloses Stake in Direct Line Insurance Takeover Code Vanguard Group Stake Disclosure Insurance Sector Direct Line
BRIEF published on 01/09/2025 at 15:12, 1 year 8 months ago Le groupe Vanguard dévoile sa participation dans Direct Line Insurance Groupe Vanguard Code De Prise De Contrôle Secteur Des Assurances Divulgation Des Enjeux Ligne Directe
PRESS RELEASE published on 01/09/2025 at 15:07, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. disclosed a 5.50% ownership in Direct Line Insurance Group plc. They made purchases of 10 10/11p ordinary shares at 2.56 GBP per unit Vanguard Group Ownership Disclosure Financial Disclosure Stock Purchases Direct Line Insurance
BRIEF published on 01/08/2025 at 15:26, 1 year 8 months ago Vanguard Group Discloses Stake in Direct Line Insurance Group Takeover Code Vanguard Group Shareholding Disclosure Direct Line Insurance Aviva
BRIEF published on 01/08/2025 at 15:26, 1 year 8 months ago Le groupe Vanguard révèle sa participation dans Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Divulgation Des Actions Aviva Assurance Ligne Directe
Published on 09/11/2026 at 04:00, 6 hours 24 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 59 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 4 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 24 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 9 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 4 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 19 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 24 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 24 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 3 hours 24 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 24 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 54 minutes ago Availability of the 2026 Interim Financial Report
